NICE To Create Single "Evaluation Pathway" For Clinical Technology In UK
This article was originally published in The Gray Sheet
Executive Summary
The U.K.'s National Institute for Health and Clinical Excellence (NICE) is developing a new work program to improve the process for identifying, evaluating and adopting effective new medical devices and diagnostics
You may also be interested in...
NICE To Seek Candidates For New-Tech Evaluation Program In First Half Of '10
Device and diagnostics companies should start thinking about products they would like to offer for evaluation under a new program in the U.K
NICE To Seek Candidates For New-Tech Evaluation Program In First Half Of '10
Device and diagnostics companies should start thinking about products they would like to offer for evaluation under a new program in the U.K
Reimbursement In Brief
MedCAC pharmacogenomics meeting: The Medicare Evidence Development and Coverage Advisory Committee will meet Jan. 27, 2010, in Baltimore to review evidence on the impact of pharmacogenomic testing on health outcomes in cancer patients. Specifically, the panel will assess assays that might be used as a guide for certain drug treatments for breast cancer, colon cancer, chronic myelogenous leukemia or metastatic colorectal cancer. The upcoming meeting is the third in a series of MedCAC discussions held this year on evidence supporting genetic and genomic screening (1"The Gray Sheet" May 25, 2009)